News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,240 Results
Type
Article (13622)
Company Profile (108)
Press Release (248510)
Section
Business (87980)
Career Advice (464)
Deals (15331)
Drug Delivery (64)
Drug Development (36553)
Employer Resources (49)
FDA (6264)
Job Trends (6190)
News (150089)
Policy (14012)
Tag
Academia (435)
Alliances (23145)
Alzheimer's disease (363)
Approvals (6275)
Artificial intelligence (66)
Bankruptcy (144)
Best Places to Work (4350)
Breast cancer (61)
Cancer (410)
Career advice (406)
Cell therapy (57)
Clinical research (30570)
Collaboration (197)
Compensation (83)
COVID-19 (748)
C-suite (58)
Data (428)
Diabetes (64)
Diagnostics (1242)
Drug discovery (43)
Drug pricing (59)
Earnings (31604)
Employer resources (43)
Events (36918)
Executive appointments (219)
FDA (6503)
Funding (132)
Gene therapy (63)
GLP-1 (303)
Government (1270)
Healthcare (3533)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5838)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3414)
Lung cancer (57)
Manufacturing (110)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9570)
Metabolic disorders (193)
Neuroscience (474)
NextGen Class of 2024 (1580)
Non-profit (591)
Northern California (498)
Obesity (113)
Opinion (112)
Patents (65)
People (28555)
Pharmaceutical (67)
Phase I (7960)
Phase II (12927)
Phase III (11611)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3178)
Radiopharmaceuticals (116)
Rare diseases (109)
Real estate (2629)
Regulatory (9893)
Research institute (563)
Resumes & cover letters (55)
Southern California (491)
Startups (1625)
United States (4908)
Vaccines (114)
Weight loss (83)
Date
Last 7 days (59)
Last 30 days (572)
Last 365 days (12247)
2025 (34)
2024 (12510)
2023 (14251)
2022 (19558)
2021 (20068)
2020 (19035)
2019 (14891)
2018 (11719)
2017 (13896)
2016 (13134)
2015 (15476)
2014 (12424)
2013 (10593)
2012 (11403)
2011 (11925)
2010 (10888)
Location
Africa (312)
Arizona (43)
Asia (19901)
Australia (2567)
California (1168)
Canada (678)
China (146)
Colorado (46)
Connecticut (48)
Europe (38935)
Florida (190)
Illinois (136)
Indiana (97)
Japan (54)
Kansas (52)
Maryland (174)
Massachusetts (1002)
Minnesota (65)
New Jersey (504)
New York (327)
North Carolina (293)
Northern California (498)
Pennsylvania (319)
South America (499)
Southern California (491)
Texas (161)
Virginia (46)
Washington State (79)
262,240 Results for "tasly pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
December 12, 2024
·
5 min read
Biotech Beach
ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)
ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research and its application to healthy aging, unveils Niagen+, the first-of-its-kind pharmaceutical-grade Niagen®.
June 13, 2024
·
9 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Press Releases
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
November 27, 2024
·
1 min read
Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.
February 29, 2024
·
3 min read
Press Releases
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
December 31, 2024
·
7 min read
Press Releases
Pharmaceutical Water Market Size to Worth USD 99.30 Bn by 2034
December 18, 2024
·
14 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Press Releases
Pharmaceutical CDMO Market Size to Surpass USD 368.70 Bn By 2034
December 17, 2024
·
13 min read
1 of 26,224
Next
